Bayer raises 2026 profit outlook on strong pharmaceutical demandBayer AG raised its annual profit outlook after better-than-expected third-quarter performance driven by demand for newer drugs in its pharmaceuticals business.Nov 3, 2026·2 sourcesCorporate earningsCancer & OncologyPharmaceutical IndustryCorporate restructuringGeneric drugsCancer treatmentCancer and Cancer TreatmentPharmaceutical earningsProduct liability law00
